Hsbc Holdings PLC Alector, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Alector, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 45,979 shares of ALEC stock, worth $88,279. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,979

Previous 47,099 2.38%

Holding current value

$88,279

Previous $213,000 0.47%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.34 - $6.58 $4,860 - $7,369	-1,120 Reduced 2.38%	45,979 $214,000
Q2 2024 Aug 12, 2024	BUY	$4.19 - $6.23 $90,382 - $134,387	21,571 Added 84.5%	47,099 $213,000
Q1 2024 May 15, 2024	SELL	$5.69 - $8.08 $49,030 - $69,625	-8,617 Reduced 25.24%	25,528 $153,000
Q4 2023 Feb 12, 2024	SELL	$3.77 - $8.39 $10,035 - $22,334	-2,662 Reduced 7.23%	34,145 $272,000
Q3 2023 Nov 13, 2023	BUY	$5.2 - $8.77 $75,254 - $126,919	14,472 Added 64.8%	36,807 $238,000
Q2 2023 Aug 11, 2023	SELL	$5.86 - $7.93 $13,987 - $18,928	-2,387 Reduced 9.66%	22,335 $134,000
Q1 2023 May 15, 2023	BUY	$5.85 - $9.84 $2,065 - $3,473	353 Added 1.45%	24,722 $153,000
Q4 2022 Feb 14, 2023	BUY	$6.88 - $9.55 $71,772 - $99,625	10,432 Added 74.85%	24,369 $224,000
Q2 2022 Aug 11, 2022	BUY	$7.65 - $14.24 $106,618 - $198,462	13,937 New	13,937 $144,000
Q1 2021 May 14, 2021	SELL	$14.84 - $22.23 $164,798 - $246,864	-11,105 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$9.4 - $16.7 $129,851 - $230,693	-13,814 Reduced 55.44%	11,105 $168,000
Q3 2020 Nov 12, 2020	BUY	$10.54 - $24.96 $42,486 - $100,613	4,031 Added 19.3%	24,919 $271,000
Q2 2020 Aug 14, 2020	BUY	$21.87 - $33.11 $96,074 - $145,452	4,393 Added 26.63%	20,888 $511,000
Q1 2020 May 15, 2020	BUY	$16.25 - $35.28 $268,043 - $581,943	16,495 New	16,495 $400,000

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Alector, Inc. Transaction History